ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,311Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 1491

$1.26M Total Retail Price of All Prescriptions

Rank: 85 out of 1491

656 Patients Receiving at Least One Drug in Part D
52% Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Georgia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

11% of this provider’s 656 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

41% of this provider’s 656 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,066 429 237 S3 1 7
LISINOPRIL 676 361 131 2 4
SIMVASTATIN 600 376 105 3 3
FUROSEMIDE 573 383 104 4 8
LEVOTHYROXINE SODIUM 559 342 90 5 2
AMLODIPINE BESYLATE 525 418 93 6 1
GABAPENTIN 443 244 85 7 13
OMEPRAZOLE 430 251 88 8 5
CARVEDILOL 417 264 77 9 17
WARFARIN SODIUM 378 271 51 10 22
METOPROLOL TARTRATE 364 243 64 11 12
ALPRAZOLAM 344 143 84 B 12 23
ATORVASTATIN CALCIUM 320 170 66 13 6
CLOPIDOGREL 292 226 52 14 18
RANITIDINE HCL 291 155 54 15 30
TRAMADOL HCL 281 163 91 16 15
METFORMIN HCL 280 163 51 17 9
PANTOPRAZOLE SODIUM 250 155 53 18 33
ZOLPIDEM TARTRATE 250 93 65 18 20
SERTRALINE HCL 228 113 40 20 26
TRAZODONE HCL 224 95 45 21 43
POTASSIUM CHLORIDE 218 109 39 22 16
DONEPEZIL HCL 207 193 29 23 34
HYDROCHLOROTHIAZIDE 199 114 44 24 11
SUBOXONE 196 20 14 S3 25 276
PRAVASTATIN SODIUM 186 109 43 26 10
NEXIUM 185 93 41 27 25
LOSARTAN POTASSIUM 182 109 40 28 14
HYDRALAZINE HCL 178 113 43 29 47
FAMOTIDINE* 176 120 28 30 46
LEVETIRACETAM 170 101 31 31 101
TRIAMTERENE-HCTZ 170 66 43 31 53
CITALOPRAM HBR 168 119 30 33 24
CLONAZEPAM 167 55 41 B 34 50
GLIPIZIDE 157 113 27 35 58
METOPROLOL SUCCINATE 154 133 33 36 19
CLONIDINE HCL 150 62 36 37 41
CARISOPRODOL 147 26 28 R 38 109
CRESTOR 144 91 30 39 27
IBUPROFEN 143 32 58 40 106
AMITRIPTYLINE HCL 141 86 23 R 41 73
CYMBALTA 140 38 16 42 51
FLUOXETINE HCL 139 73 20 43 59
ATENOLOL 129 95 23 44 21
ESCITALOPRAM OXALATE 123 76 24 45 52
NAMENDA 122 117* 18 46 36
FLUTICASONE PROPIONATE 122 42 40 46 29
NOVOLOG FLEXPEN 122 107 25 46 175
PAROXETINE HCL 119 49 21 49 72
QUETIAPINE FUMARATE 115 52 19 A 50 68
TEMAZEPAM 114 82 38 B 51 82
FENOFIBRATE* 110 69 21 52 54
ALLOPURINOL 108 95 17 53 32
AZITHROMYCIN 108 53 79 53 55
CYCLOBENZAPRINE HCL 107 37 38 R 55 75
LORAZEPAM 106 66 31 B 56 42
DIAZEPAM 101 24 24 B 57 114
OXYCODONE-ACETAMINOPHEN 99 49 17 S2 58 112
MONTELUKAST SODIUM 98 58 17 59 45
SPIRIVA 98 44 27 59 77
JANUMET 97 <11 <11 61 173
OXYCODONE HCL 96 <11 15 S2 62 125
PROMETHAZINE HCL 95 24 37 R 63 97
LOSARTAN-HYDROCHLOROTHIAZIDE 95 57 13 63 38
LEVEMIR FLEXPEN 94 78 17 65 157
SUCRALFATE 94 30 17 65 164
MELOXICAM 93 65 29 67 31
ONDANSETRON HCL* 90 33 38 68 226
ROPINIROLE HCL 90 58 15 68 87
TIZANIDINE HCL 87 14 29 70 99
RISPERIDONE 86 57 15 A 71 81
VENTOLIN HFA 85 39 35 72 117
ADVAIR DISKUS 83 51 24 73 65
FENTANYL 83 36 17 S2 73 123
LYRICA 82 51 22 75 80
OXYCODONE HCL-ACETAMINOPHEN 82 26 17 S2 75 90
PREDNISONE 82 43 36 75 44
FLUCONAZOLE 81 24 47 78 140
TAMSULOSIN HCL 80 51 15 79 35
METOCLOPRAMIDE HCL 79 47 15 80 141
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 32 20 80 28
LEVOCETIRIZINE DIHYDROCHLORIDE 77 35 22 82 239
LEVOFLOXACIN 76 45 55 83 76
DIGOX 75 75 12 84 88
VENLAFAXINE HCL ER 74 35 13 85 79
LACTULOSE 74 <11 <11 85 196
BACLOFEN 73 15 13 87 145
TOPIRAMATE 71 <11 13 88 177
ALENDRONATE SODIUM 70 51 12 89 49
DIVALPROEX SODIUM 70 31 16 89 107
OXYBUTYNIN CHLORIDE ER 69 <11 <11 91 168
FENOFIBRATE* 69 <11 <11 91 54
BUSPIRONE HCL 69 51 14 91 142
METFORMIN HCL ER 69 39 12 91 56
CIPROFLOXACIN HCL 69 39 62 91 66
GLIPIZIDE ER 69 55 16 91 91
ABILIFY 68 <11 <11 A 97 192
NAPROXEN 68 30 18 97 110
CARBIDOPA-LEVODOPA 68 51 11 97 154
LANTUS 67 <11 <11 100 57
PROAIR HFA 66 25 21 101 69
EXELON 64 <11 <11 102 121
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 29 42 102 103
OLANZAPINE 63 <11 <11 A 104 171
LEVEMIR 60 33 11 105 150
TRIAMCINOLONE ACETONIDE 58 43 26 106 146
ZETIA 57 32 12 107 67
DIOVAN 57 <11 <11 107 40
JANUVIA 56 43 15 109 61
BENAZEPRIL HCL 56 <11 <11 109 63
PROPRANOLOL HCL 55 <11 <11 111 133
GEMFIBROZIL 53 <11 <11 112 127
ISOSORBIDE MONONITRATE ER 52 <11 <11 113 64
LANTUS SOLOSTAR 51 40 11 114 92
PREMARIN 50 <11 <11 R 115 115
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.